@article{35e935b6c9c44edb9af3b9cd458286db,
title = "mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?",
keywords = "2019-nCoV Vaccine mRNA-1273, Antibodies, Viral, BNT162 Vaccine, COVID-19 Vaccines, Humans, Kidney Transplantation, Renal Dialysis, Transplant Recipients",
author = "Wijtvliet, {Veerle P W M} and Ari{\"e}n, {Kevin K} and Steven Abrams and Couttenye, {Marie M} and Fabienne Mestrez and Joachim Mari{\"e}n and {De Winter}, {Benedicte Y} and {Van Damme}, Pierre and Lissa Pipeleers and Wissing, {Karl Martin} and Daniel Abramowicz and Ledeganck, {Kristien J}",
note = "FTX",
year = "2022",
doi = "10.1093/ndt/gfab352",
language = "English",
volume = "37",
pages = "799--803",
journal = "Nephrology, Dialysis, Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "4",
}